CA2800019C - Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof - Google Patents

Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof Download PDF

Info

Publication number
CA2800019C
CA2800019C CA2800019A CA2800019A CA2800019C CA 2800019 C CA2800019 C CA 2800019C CA 2800019 A CA2800019 A CA 2800019A CA 2800019 A CA2800019 A CA 2800019A CA 2800019 C CA2800019 C CA 2800019C
Authority
CA
Canada
Prior art keywords
levocarrimycin
levoisovalerylspiramycin
iii
crystal compound
isovalerylspiramycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2800019A
Other languages
English (en)
French (fr)
Other versions
CA2800019A1 (en
Inventor
Yang Jiang
Yuyou Hao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Fuyang Pharmaceutical Technology Co Ltd
Original Assignee
Shenyang Tonglian Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Tonglian Group Co Ltd filed Critical Shenyang Tonglian Group Co Ltd
Publication of CA2800019A1 publication Critical patent/CA2800019A1/en
Application granted granted Critical
Publication of CA2800019C publication Critical patent/CA2800019C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA2800019A 2010-05-25 2011-05-25 Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof Active CA2800019C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010182027.9 2010-05-25
CN201010182027 2010-05-25
PCT/CN2011/074658 WO2011147316A1 (zh) 2010-05-25 2011-05-25 左旋可利霉素、其药物组合物、制备方法及应用

Publications (2)

Publication Number Publication Date
CA2800019A1 CA2800019A1 (en) 2011-12-01
CA2800019C true CA2800019C (en) 2015-05-26

Family

ID=44975203

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2800019A Active CA2800019C (en) 2010-05-25 2011-05-25 Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof

Country Status (17)

Country Link
US (1) US9089586B2 (https=)
EP (1) EP2578596B1 (https=)
JP (1) JP5866737B2 (https=)
KR (2) KR101706519B1 (https=)
CN (1) CN102247396B (https=)
BR (1) BR112012029905B1 (https=)
CA (1) CA2800019C (https=)
DK (1) DK2578596T3 (https=)
ES (1) ES2633737T3 (https=)
IN (1) IN2012MN02623A (https=)
MX (1) MX346873B (https=)
MY (1) MY164230A (https=)
PH (1) PH12012502329A1 (https=)
PL (1) PL2578596T3 (https=)
RU (1) RU2593499C2 (https=)
WO (1) WO2011147316A1 (https=)
ZA (1) ZA201209739B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2578595B1 (en) * 2010-05-25 2017-04-19 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Crystalline levoisovalerylspiramycin i
US9945611B2 (en) 2010-08-04 2018-04-17 Ima Life North America Inc. Bulk freeze drying using spray freezing and agitated drying
ES2649045T3 (es) * 2010-08-04 2018-01-09 Ima Life North America Inc. Liofilización a granel mediante congelación por pulverización y secado agitado
CN103694295B (zh) * 2014-01-08 2016-01-20 华东理工大学 一种优化可利霉素组分的方法
CN105497053B (zh) * 2015-12-31 2018-02-13 沈阳福洋医药科技有限公司 可利霉素在抗结核分枝杆菌感染中的应用
RU2746047C1 (ru) * 2017-04-06 2021-04-06 Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. Применение карримицина и его фармацевтически приемлемой соли для производства медикаментов для лечения и/или профилактики опухоли
RU2766176C2 (ru) * 2017-07-04 2022-02-08 Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. Применение изовалерил-спирамицина i, ii и/или iii при изготовлении препарата для лечения и/или профилактики опухоли и получения лекарственного препарата
CN110051845A (zh) * 2018-01-19 2019-07-26 沈阳福洋医药科技有限公司 一种mTOR抑制剂、药物组合物及其应用
MX2020007627A (es) * 2018-01-19 2020-11-24 Shenyang Fuyang Pharmaceutical Tech Co Ltd Uso de la carrimicina o de sus ingredientes activos.
KR20200144568A (ko) * 2018-04-17 2020-12-29 상하이 통리엔 파마슈티컬 컴퍼니 리미티드 통증 및/또는 발열을 예방 및/또는 치료하는 의약품, 조합 산물 및 그 응용
CN110384802B (zh) * 2018-04-17 2021-09-17 沈阳福洋医药科技有限公司 一种用于预防和/或治疗发热的药物、组合产品及其应用
CN110384710B (zh) * 2018-04-17 2023-01-10 沈阳福洋医药科技有限公司 一种用于预防和/或治疗疼痛的药物、组合产品及其应用
CN108992416A (zh) * 2018-09-27 2018-12-14 上海同联制药有限公司 一种可利霉素肠溶片及其制备方法
KR20220008895A (ko) * 2019-05-16 2022-01-21 쉔양 푸양 파마슈티컬 테크놀로지 컴퍼니 리미티드 섬유증을 예방, 완화 및/또는 치료하는 약물, 복합 제품 및 이의 응용
CN112239483B (zh) * 2019-07-18 2023-10-27 沈阳福洋医药科技有限公司 一种化合物及药物组合物
CN111450066B (zh) * 2020-04-24 2022-06-21 沈阳信达泰康医药科技有限公司 一种可利霉素冻干粉针制剂及其制备方法
WO2021219112A1 (zh) * 2020-04-30 2021-11-04 沈阳福洋医药科技有限公司 异戊酰螺旋霉素类化合物或其组合物在制备治疗脓毒症疾病药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5334788A (en) * 1976-09-11 1978-03-31 Sanraku Inc Antibiotics spiramycin derivatives
CN1169947C (zh) * 2002-11-19 2004-10-06 中国医学科学院医药生物技术研究所 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195
CN1237976C (zh) * 2003-12-23 2006-01-25 沈阳同联集团有限公司 必特螺旋霉素及其在抗感染性疾病中的应用
RU2007108544A (ru) * 2004-08-12 2008-09-20 Глаксосмитклайн Истраживацки Центар Загреб Д.О.О.(Hr) Применение клеточно-специфических конъюгатов для лечения воспалительных заболеваний желудочно-кишечного тракта
KR100662363B1 (ko) * 2004-10-19 2007-01-02 엘지전자 주식회사 디스플레이 기기의 인스톨 장치 및 방법
CN101054553A (zh) * 2007-04-09 2007-10-17 中国医学科学院医药生物技术研究所 异戊酰螺旋霉素i基因工程菌株的构建
CN101649325B (zh) * 2009-07-03 2011-09-07 中国医学科学院医药生物技术研究所 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术
EP2578595B1 (en) * 2010-05-25 2017-04-19 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Crystalline levoisovalerylspiramycin i

Also Published As

Publication number Publication date
MX2012013469A (es) 2013-04-03
DK2578596T3 (en) 2017-07-17
KR20130020906A (ko) 2013-03-04
EP2578596B1 (en) 2017-04-19
IN2012MN02623A (https=) 2015-06-12
BR112012029905A2 (pt) 2019-08-06
US9089586B2 (en) 2015-07-28
PL2578596T3 (pl) 2017-09-29
PH12012502329A1 (en) 2013-02-11
KR20160019970A (ko) 2016-02-22
EP2578596A4 (en) 2013-11-06
MX346873B (es) 2017-03-30
CN102247396B (zh) 2014-05-28
CN102247396A (zh) 2011-11-23
ZA201209739B (en) 2014-03-26
JP5866737B2 (ja) 2016-02-17
WO2011147316A1 (zh) 2011-12-01
RU2012156419A (ru) 2014-06-27
KR101625262B1 (ko) 2016-05-27
RU2593499C2 (ru) 2016-08-10
KR101706519B1 (ko) 2017-02-14
CA2800019A1 (en) 2011-12-01
US20130150316A1 (en) 2013-06-13
EP2578596A1 (en) 2013-04-10
MY164230A (en) 2017-11-30
ES2633737T3 (es) 2017-09-25
JP2013528167A (ja) 2013-07-08
BR112012029905B1 (pt) 2022-01-11

Similar Documents

Publication Publication Date Title
CA2800019C (en) Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof
CA2800021C (en) Levoisovalerylspiramycin i, ii, iii and preparations, preparation methods and uses thereof
CN102229634B (zh) 左旋异戊酰螺旋霉素i、其制剂、制备方法及应用
CN102260308B (zh) 左旋异戊酰螺旋霉素iii、其制剂、制备方法及应用
CN102311471B (zh) 左旋异戊酰螺旋霉素ii、其制剂、制备方法及应用

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130424

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241115

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241115

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD

Year of fee payment: 14

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250519

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250519

R00 Party data change recorded

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R00-R100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: SMALL ENTITY DECLARATION REQUEST RECEIVED

Effective date: 20250626

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250626